nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—Extravasation—Carboplatin—esophageal cancer	0.0472	0.0645	CcSEcCtD
Nafcillin—Phlebitis—Carboplatin—esophageal cancer	0.0347	0.0474	CcSEcCtD
Nafcillin—Skin necrosis—Cisplatin—esophageal cancer	0.0346	0.0472	CcSEcCtD
Nafcillin—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.0249	0.0341	CcSEcCtD
Nafcillin—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.0199	0.0271	CcSEcCtD
Nafcillin—Skin necrosis—Methotrexate—esophageal cancer	0.019	0.0259	CcSEcCtD
Nafcillin—Hepatotoxicity—Cisplatin—esophageal cancer	0.0156	0.0214	CcSEcCtD
Nafcillin—Necrosis—Cisplatin—esophageal cancer	0.0154	0.021	CcSEcCtD
Nafcillin—Nephropathy—Methotrexate—esophageal cancer	0.0139	0.019	CcSEcCtD
Nafcillin—Extravasation—Cisplatin—esophageal cancer	0.0138	0.0189	CcSEcCtD
Nafcillin—Bone marrow depression—Capecitabine—esophageal cancer	0.0132	0.018	CcSEcCtD
Nafcillin—Pain—Carboplatin—esophageal cancer	0.0126	0.0172	CcSEcCtD
Nafcillin—Body temperature increased—Carboplatin—esophageal cancer	0.0116	0.0159	CcSEcCtD
Nafcillin—Skin exfoliation—Cisplatin—esophageal cancer	0.0115	0.0158	CcSEcCtD
Nafcillin—Hepatotoxicity—Capecitabine—esophageal cancer	0.0115	0.0158	CcSEcCtD
Nafcillin—Phlebitis—Cisplatin—esophageal cancer	0.0102	0.0139	CcSEcCtD
Nafcillin—Proteinuria—Capecitabine—esophageal cancer	0.0101	0.0138	CcSEcCtD
Nafcillin—Protein urine present—Capecitabine—esophageal cancer	0.00999	0.0137	CcSEcCtD
Nafcillin—Bone marrow depression—Methotrexate—esophageal cancer	0.00982	0.0134	CcSEcCtD
Nafcillin—Inflammation—Capecitabine—esophageal cancer	0.00918	0.0125	CcSEcCtD
Nafcillin—Hepatotoxicity—Methotrexate—esophageal cancer	0.00858	0.0117	CcSEcCtD
Nafcillin—Skin exfoliation—Capecitabine—esophageal cancer	0.0085	0.0116	CcSEcCtD
Nafcillin—Necrosis—Methotrexate—esophageal cancer	0.00844	0.0115	CcSEcCtD
Nafcillin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—esophageal cancer	0.00829	0.0309	CbGpPWpGaD
Nafcillin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00789	0.0108	CcSEcCtD
Nafcillin—Extravasation—Methotrexate—esophageal cancer	0.0076	0.0104	CcSEcCtD
Nafcillin—Proteinuria—Methotrexate—esophageal cancer	0.00754	0.0103	CcSEcCtD
Nafcillin—Phlebitis—Capecitabine—esophageal cancer	0.0075	0.0102	CcSEcCtD
Nafcillin—Thrombophlebitis—Capecitabine—esophageal cancer	0.00747	0.0102	CcSEcCtD
Nafcillin—Protein urine present—Methotrexate—esophageal cancer	0.00744	0.0102	CcSEcCtD
Nafcillin—Swelling—Capecitabine—esophageal cancer	0.00733	0.01	CcSEcCtD
Nafcillin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00726	0.00992	CcSEcCtD
Nafcillin—Pancytopenia—Cisplatin—esophageal cancer	0.0072	0.00983	CcSEcCtD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00698	0.026	CbGpPWpGaD
Nafcillin—Inflammation—Methotrexate—esophageal cancer	0.00683	0.00933	CcSEcCtD
Nafcillin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00682	0.0254	CbGpPWpGaD
Nafcillin—Renal impairment—Capecitabine—esophageal cancer	0.00679	0.00928	CcSEcCtD
Nafcillin—Renal failure—Cisplatin—esophageal cancer	0.00664	0.00907	CcSEcCtD
Nafcillin—Stomatitis—Cisplatin—esophageal cancer	0.00659	0.009	CcSEcCtD
Nafcillin—Skin exfoliation—Methotrexate—esophageal cancer	0.00633	0.00864	CcSEcCtD
Nafcillin—CYP1A2—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00614	0.0229	CbGpPWpGaD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00612	0.0228	CbGpPWpGaD
Nafcillin—Liver function test abnormal—Capecitabine—esophageal cancer	0.00597	0.00815	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00582	0.00795	CcSEcCtD
Nafcillin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.00569	0.0212	CbGpPWpGaD
Nafcillin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00556	0.00759	CcSEcCtD
Nafcillin—Bronchospasm—Capecitabine—esophageal cancer	0.00549	0.00751	CcSEcCtD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00539	0.0201	CbGpPWpGaD
Nafcillin—Abdominal discomfort—Capecitabine—esophageal cancer	0.00535	0.00731	CcSEcCtD
Nafcillin—Pancytopenia—Capecitabine—esophageal cancer	0.0053	0.00725	CcSEcCtD
Nafcillin—Neutropenia—Capecitabine—esophageal cancer	0.00522	0.00714	CcSEcCtD
Nafcillin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.00518	0.0193	CbGpPWpGaD
Nafcillin—Ill-defined disorder—Cisplatin—esophageal cancer	0.0049	0.00669	CcSEcCtD
Nafcillin—Renal failure—Capecitabine—esophageal cancer	0.0049	0.00669	CcSEcCtD
Nafcillin—Stomatitis—Capecitabine—esophageal cancer	0.00485	0.00663	CcSEcCtD
Nafcillin—Malaise—Cisplatin—esophageal cancer	0.00476	0.0065	CcSEcCtD
Nafcillin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00476	0.0178	CbGpPWpGaD
Nafcillin—Haematuria—Capecitabine—esophageal cancer	0.00475	0.00649	CcSEcCtD
Nafcillin—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00474	0.0177	CbGpPWpGaD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00472	0.0176	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.00465	0.0174	CbGpPWpGaD
Nafcillin—Agranulocytosis—Capecitabine—esophageal cancer	0.00465	0.00635	CcSEcCtD
Nafcillin—Myalgia—Cisplatin—esophageal cancer	0.00449	0.00614	CcSEcCtD
Nafcillin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00444	0.00607	CcSEcCtD
Nafcillin—Discomfort—Cisplatin—esophageal cancer	0.00444	0.00607	CcSEcCtD
Nafcillin—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00436	0.0163	CbGpPWpGaD
Nafcillin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00435	0.0162	CbGpPWpGaD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00431	0.0161	CbGpPWpGaD
Nafcillin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00431	0.00589	CcSEcCtD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00418	0.0156	CbGpPWpGaD
Nafcillin—Eosinophilia—Methotrexate—esophageal cancer	0.00412	0.00562	CcSEcCtD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00405	0.0151	CbGpPWpGaD
Nafcillin—Hypotension—Cisplatin—esophageal cancer	0.00403	0.0055	CcSEcCtD
Nafcillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.004	0.0149	CbGpPWpGaD
Nafcillin—Abdominal discomfort—Methotrexate—esophageal cancer	0.00399	0.00545	CcSEcCtD
Nafcillin—Pancytopenia—Methotrexate—esophageal cancer	0.00395	0.00539	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00393	0.00536	CcSEcCtD
Nafcillin—Neutropenia—Methotrexate—esophageal cancer	0.00389	0.00531	CcSEcCtD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—esophageal cancer	0.00386	0.0144	CbGpPWpGaD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00373	0.0139	CbGpPWpGaD
Nafcillin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00372	0.00508	CcSEcCtD
Nafcillin—Pain—Cisplatin—esophageal cancer	0.00368	0.00503	CcSEcCtD
Nafcillin—Renal failure—Methotrexate—esophageal cancer	0.00364	0.00498	CcSEcCtD
Nafcillin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00362	0.0135	CbGpPWpGaD
Nafcillin—Stomatitis—Methotrexate—esophageal cancer	0.00361	0.00494	CcSEcCtD
Nafcillin—Ill-defined disorder—Capecitabine—esophageal cancer	0.00361	0.00493	CcSEcCtD
Nafcillin—Feeling abnormal—Cisplatin—esophageal cancer	0.00355	0.00485	CcSEcCtD
Nafcillin—Haematuria—Methotrexate—esophageal cancer	0.00353	0.00483	CcSEcCtD
Nafcillin—Malaise—Capecitabine—esophageal cancer	0.00351	0.00479	CcSEcCtD
Nafcillin—Agranulocytosis—Methotrexate—esophageal cancer	0.00346	0.00473	CcSEcCtD
Nafcillin—Body temperature increased—Cisplatin—esophageal cancer	0.00341	0.00465	CcSEcCtD
Nafcillin—CYP1A2—Xenobiotics—CYP2A6—esophageal cancer	0.00339	0.0127	CbGpPWpGaD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00333	0.0124	CbGpPWpGaD
Nafcillin—Arthralgia—Capecitabine—esophageal cancer	0.00331	0.00453	CcSEcCtD
Nafcillin—Myalgia—Capecitabine—esophageal cancer	0.00331	0.00453	CcSEcCtD
Nafcillin—Discomfort—Capecitabine—esophageal cancer	0.00327	0.00447	CcSEcCtD
Nafcillin—CYP1A2—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00326	0.0122	CbGpPWpGaD
Nafcillin—Hypersensitivity—Cisplatin—esophageal cancer	0.00317	0.00434	CcSEcCtD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00313	0.0117	CbGpPWpGaD
Nafcillin—Shock—Capecitabine—esophageal cancer	0.00312	0.00427	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00311	0.0116	CbGpPWpGaD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00311	0.0116	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen metabolism—CYP1B1—esophageal cancer	0.00297	0.0111	CbGpPWpGaD
Nafcillin—Hypotension—Capecitabine—esophageal cancer	0.00297	0.00405	CcSEcCtD
Nafcillin—Diarrhoea—Cisplatin—esophageal cancer	0.00295	0.00403	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00289	0.00395	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00278	0.0104	CbGpPWpGaD
Nafcillin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00274	0.00375	CcSEcCtD
Nafcillin—Vomiting—Cisplatin—esophageal cancer	0.00274	0.00374	CcSEcCtD
Nafcillin—Rash—Cisplatin—esophageal cancer	0.00272	0.00371	CcSEcCtD
Nafcillin—Pain—Capecitabine—esophageal cancer	0.00272	0.00371	CcSEcCtD
Nafcillin—Dermatitis—Cisplatin—esophageal cancer	0.00271	0.00371	CcSEcCtD
Nafcillin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00269	0.00367	CcSEcCtD
Nafcillin—CYP1A2—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00263	0.00981	CbGpPWpGaD
Nafcillin—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00262	0.00977	CbGpPWpGaD
Nafcillin—Feeling abnormal—Capecitabine—esophageal cancer	0.00262	0.00358	CcSEcCtD
Nafcillin—Malaise—Methotrexate—esophageal cancer	0.00261	0.00357	CcSEcCtD
Nafcillin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.0026	0.00355	CcSEcCtD
Nafcillin—Nausea—Cisplatin—esophageal cancer	0.00256	0.0035	CcSEcCtD
Nafcillin—Urticaria—Capecitabine—esophageal cancer	0.00252	0.00345	CcSEcCtD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00252	0.00939	CbGpPWpGaD
Nafcillin—Body temperature increased—Capecitabine—esophageal cancer	0.00251	0.00343	CcSEcCtD
Nafcillin—Abdominal pain—Capecitabine—esophageal cancer	0.00251	0.00343	CcSEcCtD
Nafcillin—Myalgia—Methotrexate—esophageal cancer	0.00247	0.00337	CcSEcCtD
Nafcillin—Arthralgia—Methotrexate—esophageal cancer	0.00247	0.00337	CcSEcCtD
Nafcillin—Discomfort—Methotrexate—esophageal cancer	0.00244	0.00333	CcSEcCtD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.0024	0.00897	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.0024	0.00897	CbGpPWpGaD
Nafcillin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00236	0.00323	CcSEcCtD
Nafcillin—Hypersensitivity—Capecitabine—esophageal cancer	0.00234	0.0032	CcSEcCtD
Nafcillin—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.0023	0.00857	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00225	0.00839	CbGpPWpGaD
Nafcillin—Pruritus—Capecitabine—esophageal cancer	0.00225	0.00307	CcSEcCtD
Nafcillin—CYP1A2—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00223	0.00832	CbGpPWpGaD
Nafcillin—Hypotension—Methotrexate—esophageal cancer	0.00221	0.00302	CcSEcCtD
Nafcillin—Diarrhoea—Capecitabine—esophageal cancer	0.00217	0.00297	CcSEcCtD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00216	0.00807	CbGpPWpGaD
Nafcillin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00215	0.00294	CcSEcCtD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00214	0.00799	CbGpPWpGaD
Nafcillin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00204	0.00279	CcSEcCtD
Nafcillin—CYP1A2—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00203	0.00758	CbGpPWpGaD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00203	0.00757	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.00203	0.00756	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00203	0.00756	CbGpPWpGaD
Nafcillin—Pain—Methotrexate—esophageal cancer	0.00202	0.00276	CcSEcCtD
Nafcillin—Vomiting—Capecitabine—esophageal cancer	0.00202	0.00276	CcSEcCtD
Nafcillin—Rash—Capecitabine—esophageal cancer	0.002	0.00274	CcSEcCtD
Nafcillin—Dermatitis—Capecitabine—esophageal cancer	0.002	0.00273	CcSEcCtD
Nafcillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00198	0.00738	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00198	0.00738	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00198	0.00738	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00197	0.00733	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00195	0.00728	CbGpPWpGaD
Nafcillin—Feeling abnormal—Methotrexate—esophageal cancer	0.00195	0.00266	CcSEcCtD
Nafcillin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00193	0.00264	CcSEcCtD
Nafcillin—Nausea—Capecitabine—esophageal cancer	0.00189	0.00258	CcSEcCtD
Nafcillin—Urticaria—Methotrexate—esophageal cancer	0.00188	0.00257	CcSEcCtD
Nafcillin—Abdominal pain—Methotrexate—esophageal cancer	0.00187	0.00255	CcSEcCtD
Nafcillin—Body temperature increased—Methotrexate—esophageal cancer	0.00187	0.00255	CcSEcCtD
Nafcillin—CYP1A2—Tryptophan metabolism—ALDH2—esophageal cancer	0.00185	0.00691	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.0018	0.00671	CbGpPWpGaD
Nafcillin—Hypersensitivity—Methotrexate—esophageal cancer	0.00174	0.00238	CcSEcCtD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00172	0.00643	CbGpPWpGaD
Nafcillin—Pruritus—Methotrexate—esophageal cancer	0.00167	0.00229	CcSEcCtD
Nafcillin—Diarrhoea—Methotrexate—esophageal cancer	0.00162	0.00221	CcSEcCtD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.0016	0.00598	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00154	0.00576	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00153	0.00569	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00152	0.00566	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00151	0.00562	CbGpPWpGaD
Nafcillin—Vomiting—Methotrexate—esophageal cancer	0.0015	0.00205	CcSEcCtD
Nafcillin—Rash—Methotrexate—esophageal cancer	0.00149	0.00204	CcSEcCtD
Nafcillin—Dermatitis—Methotrexate—esophageal cancer	0.00149	0.00203	CcSEcCtD
Nafcillin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00147	0.0055	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00143	0.00534	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00141	0.00526	CbGpPWpGaD
Nafcillin—Nausea—Methotrexate—esophageal cancer	0.0014	0.00192	CcSEcCtD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.0014	0.00524	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.0014	0.00524	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.0014	0.00524	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00139	0.00519	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTO1—esophageal cancer	0.00135	0.00505	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00133	0.00496	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00132	0.00493	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00131	0.0049	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00124	0.00461	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00123	0.0046	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00121	0.00453	CbGpPWpGaD
Nafcillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00119	0.00445	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00116	0.00433	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00114	0.00426	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00114	0.00424	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00114	0.00424	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00112	0.00418	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.0011	0.0041	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00109	0.00408	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00109	0.00406	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00108	0.00404	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00108	0.00404	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00107	0.004	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00107	0.00398	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00105	0.00393	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	0.00105	0.00391	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00105	0.00391	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—ADH7—esophageal cancer	0.00104	0.0039	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00102	0.0038	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00101	0.00375	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00101	0.00375	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000937	0.0035	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00092	0.00343	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	0.000916	0.00342	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000881	0.00329	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000876	0.00327	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000865	0.00323	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000865	0.00323	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	0.000851	0.00318	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000839	0.00313	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000835	0.00312	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000824	0.00307	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000813	0.00303	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000806	0.00301	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.000791	0.00295	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.00078	0.00291	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.00077	0.00287	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000762	0.00284	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00071	0.00265	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000707	0.00264	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000691	0.00258	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000668	0.00249	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000657	0.00245	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000648	0.00242	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000645	0.00241	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000633	0.00236	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000614	0.00229	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000611	0.00228	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000606	0.00226	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000602	0.00225	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000592	0.00221	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000575	0.00215	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000553	0.00206	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000526	0.00196	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000526	0.00196	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000498	0.00186	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000489	0.00182	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000482	0.0018	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000474	0.00177	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000472	0.00176	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000468	0.00175	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.00046	0.00172	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000459	0.00171	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000453	0.00169	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000449	0.00167	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000449	0.00167	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000444	0.00166	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000421	0.00157	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000404	0.00151	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000377	0.00141	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000372	0.00139	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000355	0.00132	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00035	0.00131	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000319	0.00119	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000278	0.00104	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00027	0.00101	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000247	0.000922	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000247	0.000922	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000221	0.000824	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.00021	0.000784	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CA1—esophageal cancer	0.00021	0.000784	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CA2—esophageal cancer	0.000192	0.000717	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000191	0.000711	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000191	0.000711	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000188	0.000701	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000179	0.000666	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000179	0.000666	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000176	0.000659	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CA1—esophageal cancer	0.000162	0.000605	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000162	0.000605	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000157	0.000584	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TYMP—esophageal cancer	0.00015	0.000558	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CA2—esophageal cancer	0.000148	0.000553	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000146	0.000543	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000142	0.000529	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000138	0.000514	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000138	0.000514	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000135	0.000505	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000135	0.000505	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.00013	0.000484	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000125	0.000466	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000124	0.000462	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000121	0.000451	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000118	0.000439	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000115	0.000431	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000112	0.000419	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.00011	0.000412	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000109	0.000409	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.000105	0.000392	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000104	0.00039	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000104	0.00039	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	0.000104	0.000387	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000103	0.000386	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.0001	0.000374	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTGS1—esophageal cancer	9.83e-05	0.000367	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ENO1—esophageal cancer	9.83e-05	0.000367	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PSME2—esophageal cancer	9.69e-05	0.000362	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PSME1—esophageal cancer	9.69e-05	0.000362	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.64e-05	0.00036	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.55e-05	0.000356	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GNG7—esophageal cancer	9.09e-05	0.000339	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.51e-05	0.000318	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.46e-05	0.000316	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	8.36e-05	0.000312	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.1e-05	0.000302	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8e-05	0.000299	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.86e-05	0.000293	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ENO1—esophageal cancer	7.59e-05	0.000283	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.59e-05	0.000283	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PSME1—esophageal cancer	7.48e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PSME2—esophageal cancer	7.48e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HMOX1—esophageal cancer	7.17e-05	0.000268	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.04e-05	0.000263	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.88e-05	0.000257	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.45e-05	0.000241	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.07e-05	0.000226	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.54e-05	0.000207	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.31e-05	0.000198	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.21e-05	0.000194	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.6e-05	0.000172	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NOS3—esophageal cancer	4.12e-05	0.000154	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.77e-05	0.000141	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.55e-05	0.000133	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NOS3—esophageal cancer	3.18e-05	0.000119	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—EP300—esophageal cancer	3.13e-05	0.000117	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.91e-05	0.000109	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—EP300—esophageal cancer	2.42e-05	9.02e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.32e-05	8.65e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.79e-05	6.68e-05	CbGpPWpGaD
